NASUS PHARMA LTD (NSRX) Stock Price & Overview
NYSEARCA:NSRX • IL0012181553
Current stock price
The current stock price of NSRX is 2.3 USD. Today NSRX is down by -2.13%. In the past month the price decreased by -52.67%.
NSRX Key Statistics
- Market Cap
- 26.933M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- N/A
- Dividend Yield
- N/A
NSRX Stock Performance
NSRX Stock Chart
NSRX Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to NSRX.
NSRX Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to NSRX. NSRX may be in some trouble as it scores bad on both profitability and health.
NSRX Earnings
NSRX Forecast & Estimates
8 analysts have analysed NSRX and the average price target is 20.91 USD. This implies a price increase of 809.13% is expected in the next year compared to the current price of 2.3.
NSRX Groups
Sector & Classification
NSRX Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -442.86% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
NSRX Ownership
NSRX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 26.52 | 882.589B | ||
| JNJ | JOHNSON & JOHNSON | 20.69 | 585.389B | ||
| MRK | MERCK & CO. INC. | 23.35 | 298.838B | ||
| PFE | PFIZER INC | 9.32 | 161.094B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.37 | 121.374B | ||
| ZTS | ZOETIS INC | 16.71 | 49.786B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.16 | 28.018B | ||
| VTRS | VIATRIS INC | 5.35 | 15.475B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 21.69 | 11.475B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.619B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.372B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 5.599B | ||
| CORT | CORCEPT THERAPEUTICS INC | 49.44 | 4.52B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NSRX
Company Profile
Nasus Pharma Ltd. engages in the development of intranasal drugs for emergency medical conditions. The firm conducts ins business activities as a pharmaceutical preparation and intranasal powder-based drug delivery systems manufacturer. Its microsphere technology enables rapid, non-invasive administration of medications for conditions such as anaphylaxis and opioid overdose among others. Nasus Pharma Ltd's formulations are designed for relatively fast absorption, ease of use, and effectiveness in critical situations (such as emergency use). The firm's products predominantly aim to improve access to life-saving treatments by allowing easy administration by caregivers or non-professionals, as well as medical doctors and emergency nurses.
Company Info
IPO: 2025-08-13
NASUS PHARMA LTD
Yigal Alon 65
TEL AVIV-YAFO IL
Employees: 0
Phone: 97237326616
NASUS PHARMA LTD / NSRX FAQ
What does NASUS PHARMA LTD do?
Nasus Pharma Ltd. engages in the development of intranasal drugs for emergency medical conditions. The firm conducts ins business activities as a pharmaceutical preparation and intranasal powder-based drug delivery systems manufacturer. Its microsphere technology enables rapid, non-invasive administration of medications for conditions such as anaphylaxis and opioid overdose among others. Nasus Pharma Ltd's formulations are designed for relatively fast absorption, ease of use, and effectiveness in critical situations (such as emergency use). The firm's products predominantly aim to improve access to life-saving treatments by allowing easy administration by caregivers or non-professionals, as well as medical doctors and emergency nurses.
What is the current price of NSRX stock?
The current stock price of NSRX is 2.3 USD. The price decreased by -2.13% in the last trading session.
Does NSRX stock pay dividends?
NSRX does not pay a dividend.
What is the ChartMill rating of NASUS PHARMA LTD stock?
NSRX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the number of employees for NASUS PHARMA LTD?
NASUS PHARMA LTD (NSRX) currently has 0 employees.
Can you provide the market cap for NASUS PHARMA LTD?
NASUS PHARMA LTD (NSRX) has a market capitalization of 26.93M USD. This makes NSRX a Nano Cap stock.